Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10.

Journal of virology - 1 Aug 2007

Manrique Amapola, Rusert Peter, Joos Beda, Fischer Marek, Kuster Herbert, Leemann Christine, Niederöst Barbara, Weber Rainer, Stiegler Gabriela, Katinger Hermann, Günthard Huldrych F, Trkola Alexandra

Abstract excerpt

Recently, passive immunization of human immunodeficiency virus (HIV)-infected individuals with monoclonal antibodies (MAbs) 2G12, 2F5, and 4E10 provided evidence of the in vivo activity of 2G12 but raised concerns about the function of the two membrane-proximal external region (MPER)-specific MAb...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Drug Resistance, Viral
Share to Epitopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycosylation

Share to HIV Antibodies

Share to HIV Infections

Share to Sequence Analysis, RNA

Source

Open in PubMed Open full text

Identifiers

PMID: 17567707
DOI: 10.1128/JVI.00598-07
PMCID: PMC1951363

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17567707-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10.PMID 17567707Read ↗

HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies.Semantic proximity Read ↗

In Vivo gp41 Antibodies Targeting the 2F5 Monoclonal Antibody Epitope Mediate Human Immunodeficiency Virus Type 1 Neutralization BreadthSemantic proximity Read ↗

Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus.Semantic proximity Read ↗

4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms.Semantic proximity Read ↗

HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans.Semantic proximity Read ↗

Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies <i>in vivo</i>Semantic proximity Read ↗

Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo.Semantic proximity Read ↗

Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies.Semantic proximity Read ↗

Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.Semantic proximity Read ↗

Dual role of glycosylation in resistance to CD4-binding site broadly neutralizing antibodies.Semantic proximity Read ↗

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.Semantic proximity Read ↗

Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.